Diagnostic value of circulating microRNA-21 in chronic lung allograft dysfunction after bilateral cadaveric and living-donor lobar lung transplantation

• Published in: Heliyon Vol. 9; no. 4; p. e14903
• Main Authors: Shiotani, Toshio, Sugimoto, Seiichiro, Tomioka, Yasuaki, Yamamoto, Haruchika, Tanaka, Shin, Miyoshi, Kentaroh, Suzawa, Ken, Shien, Kazuhiko, Yamamoto, Hiromasa, Okazaki, Mikio, Toyooka, Shinichi
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.04.2023; Elsevier
• Subjects: Biomarker; Chronic lung allograft dysfunction; Living-donor lobar lung transplantation; Lung transplantation; Micro-RNA; Biomarker; RAS; Lung transplantation; LT; CLT; mRNA; TLC; ISHLT; AUC; CLAD; LDLLT; miRNA; TGF-β; BOS; ROC; Micro-RNA; Chronic lung allograft dysfunction; PGD; AR; CT; FVC; FEV1; Living-donor lobar lung transplantation; HLA; LAS
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2023.e14903

MicroRNAs (miRNAs) involved in the pathogenesis of pulmonary fibrosis have been shown to be associated with the development of chronic lung allograft dysfunction (CLAD) after lung transplantation (LT). We investigated the role of circulating miRNAs in the diagnosis of CLAD after bilateral LT, including cadaveric LT (CLT) and living-donor lobar LT (LDLLT). The subjects of this retrospective study were 37 recipients of bilateral CLT (n = 23) and LDLLT (n = 14), and they were divided into a non-CLAD group (n = 24) and a CLAD group (n = 13). The plasma miRNA levels of the two groups were compared, and correlations between their miRNAs levels and percent baseline forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and total lung capacity (TLC) values were calculated from one year before to one year after the diagnosis of CLAD. The plasma levels of both miR-21 and miR-155 at the time of the diagnosis of CLAD were significantly higher in the CLAD group than in the non-CLAD group (miR-21, P = 0.0013; miR-155, P = 0.042). The miR-21 levels were significantly correlated with the percent baseline FEV1, FVC, and TLC value of one year before and at the time of diagnosis of CLAD (P < 0.05). A receiver operating characteristic curve analysis of the performance of miR-21 levels in the diagnosis of CLAD yielded an area under the curve of 0.89. Circulating miR-21 appears to be of potential value in diagnosing CLAD after bilateral LT.